OpenAI and Sam Altman Sued Over Alleged Harmful ChatGPT Medical Advice
A Florida pastor is suing OpenAI and its chief executive, claiming ChatGPT provided inaccurate medical guidance that delayed treatment for a life-threatening pulmonary embolism, highlighting emerging liability risks for artificial intelligence providers.
OpenAI and Chief Executive Sam Altman have been named as defendants in a new lawsuit filed by a 55-year-old Florida pastor. The plaintiff alleges that the company’s chatbot, ChatGPT, provided him with personalized and inaccurate medical advice that brought him to the brink of death.
According to the legal complaint, the man relied on health guidance generated by the chatbot, which led him to delay seeking professional medical attention. The artificial intelligence system allegedly assessed his reported symptoms as not likely very dangerous.
In reality, the pain the plaintiff experienced was the onset of a pulmonary embolism, a severe medical condition that nearly proved fatal. The lawsuit centers on the assertion that relying on this automated guidance directly caused a dangerous delay in his necessary medical treatment.
Eric Fish, a partner at the law firm Hooper, Lundy & Bookman, has provided analysis on the matter. He broke down the legal merits and potential viability of the lawsuit.
For financial markets and technology executives, this case underscores a growing area of legal and financial exposure for generative AI companies. As users increasingly interact with large language models for specialized guidance, providers face mounting scrutiny over their liability for harmful real-world outcomes.
Investors in the artificial intelligence sector are closely watching how courts will allocate responsibility when automated systems deliver advice in high-stakes domains like healthcare. The legal proceedings could establish critical precedents for product liability.
Furthermore, the case will test the limits of current corporate indemnity shields and user agreement disclaimers. If courts hold AI developers accountable for personalized outputs, it could force significant operational and compliance changes across the technology industry.